Annis Gardner Whiting Capital Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.86M Sell
7,897
-72
-0.9% -$24.6K 0.43% 39
2026
Q1
$2.8M Buy
7,969
+127
+2% +$45.3K 0.45% 32
2025
Q4
$2.57M Buy
7,842
+854
+12% +$271K 0.49% 29
2025
Q3
$1.97M Buy
6,988
+852
+14% +$247K 0.41% 39
2025
Q2
$1.71M Buy
6,136
+452
+8% +$128K 0.59% 31
2025
Q1
$1.77M Buy
5,684
+19
+0.3% +$5.61K 0.75% 23
2024
Q4
$1.48M Buy
5,665
+97
+2% +$28.8K 0.41% 47
2024
Q3
$1.79M Sell
5,568
-929
-14% -$304K 0.51% 31
2024
Q2
$2.03M Buy
6,497
+3,628
+126% +$1.07M 0.58% 22
2024
Q1
$816K Buy
2,869
+977
+52% +$286K 0.29% 65
2023
Q4
$545K Buy
1,892
+195
+11% +$53.1K 0.24% 80
2023
Q3
$456K Buy
+1,697
New +$423K 0.24% 81

Other funds holding AMGN

Annis Gardner Whiting Capital Advisors's AMGN Position: Q2 2026 in Review

Annis Gardner Whiting Capital Advisors reduced its Amgen (AMGN) stake by 0.9% in Q2 2026, selling an estimated $24.6K and leaving 7,897 shares worth $2.86M. The position accounts for 0.43% of the portfolio, ranked #39.

Annis Gardner Whiting Capital Advisors first reported a position in AMGN in Q3 2023 and has held it in 12 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Annis Gardner Whiting Capital Advisors held 7,897 shares of Amgen worth $2.86M as of Q2 2026.
  • Annis Gardner Whiting Capital Advisors sold 72 Amgen shares in Q2 2026, an estimated $24.6K.
  • Amgen made up 0.43% of Annis Gardner Whiting Capital Advisors's portfolio in Q2 2026, its #39 holding.
  • Annis Gardner Whiting Capital Advisors first reported a position in Amgen in Q3 2023 and has held it in 12 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.